Technology | 2018.09.05
Aucta Pharmaceuticals Signs Commercial Manufacturing Agreement with Catalent for Vigabatrin Stick Pack Dosage Form
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced a commercial supply agreement with Aucta Pharmaceuticals, Inc.’s (Aucta) vigabatrin. The agreement follows a successful development program to formulate vigabatrin into a novel dosage form that employs Catalent’s proprietary FlexDose services.
(PRWeb September 04, 2018)
Read the full story at https://www.prweb.com/releases/aucta_pharmaceuticals_signs_commercial_manufacturing_agreement_with_catalent_for_vigabatrin_stick_pack_dosage_form/prweb15733659.htm
For more information, please visit
https://www.prweb.com/releases/aucta_pha[...]_dosage_form/prweb15733659.htm
